Reduced Iron Toxicity
Identifiers
What are the material safety considerations for Reduced Iron?
Reduced Iron presents physical hazards as a flammable solid (H228) and self-heating substance (H251), requiring danger labeling. It also causes serious eye irritation (H319) and respiratory irritation (H335). Toxicologically, oral iron poisoning is a key risk, with ingestions over 30 mg/kg warranting hospital observation; acute toxicity in rats is reported at 60 mg/kg oral. Chronic oral reference doses are 0.7 mg/kg-day. These hazards necessitate careful handling and exposure control in formulation and manufacturing settings.
How should hazard classifications and toxicology findings for Reduced Iron be interpreted together?
The GHS classifications and toxicology data together indicate that Reduced Iron's primary risks are physical (flammability) and irritation, while systemic toxicity is dose-dependent and primarily associated with oral overexposure. The chronic reference dose of 0.7 mg/kg-day provides a benchmark for safe exposure, but the acute toxicity data (e.g., 30 mg/kg oral for hospital admission) highlight a narrow margin between therapeutic and toxic doses. This dual profile means safety assessments must separately address occupational exposure (dust/eye) and accidental ingestion risks.
Which exposure routes, dose contexts, or effects are material for Reduced Iron?
Material exposure routes for Reduced Iron include inhalation of respirable dust, dermal/eye contact, and accidental oral ingestion. Occupational exposure limits include an 8-hour TWA of 5 mg/m³ for respirable iron oxide (ACGIH) and 1 mg/m³ for other settings. Iron absorption varies from 10-35% in normal individuals up to 95% in iron-deficient subjects, making dose context critical. Eye and respiratory irritation are acute effects, while chronic oral exposure is governed by a reference dose of 0.7 mg/kg-day.
Which handling and risk-management measures are relevant for Reduced Iron?
Handling measures should prioritize preventing dust generation and ignition sources due to flammability and self-heating properties. Use local exhaust ventilation and respiratory protection to maintain airborne levels below the 1 mg/m³ REL. Eye protection is essential to prevent serious irritation. For oral exposure, secure storage and child-resistant packaging are critical, given the toxicity threshold of 30 mg/kg. First aid for skin contact with molten material requires medical assistance. These controls mitigate both physical and toxicological risks.
Which safety evidence gaps should be resolved before making decisions about Reduced Iron?
Before finalizing safety decisions, clarify whether Reduced Iron's GHS classifications apply to the specific particle size and form used, as notification ratios vary (e.g., H228 at 15.5% vs 100%). Also, obtain Reduced Iron-specific exposure limits and toxicity data, as current values are derived from iron oxide or iron compounds. The carcinogenic potential is inadequately assessed, and the chronic reference dose is based on a 2006 PPRTV assessment. These gaps affect regulatory classification and occupational exposure limit setting.